Publications
2 shownA phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse
A randomized, multicentre, open-label, phase II study compared temozolomide (TMZ), an oral second-generation alkylating agent, and procarbazine (PCB) in 225 patients with gliobl...
Frequent Co-Authors
Researcher Info
- h-index
- 2
- Publications
- 2
- Citations
- 8,508
- Institution
- The University of Texas MD Anderson Cancer Center
External Links
Identifiers
- ORCID
- 0000-0002-1669-0793
Impact Metrics
h-index
2
h-index: Number of publications with at least h citations each.